Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effects of dipyridamole on left ventricular function.

P Weinmann1, J L Moretti

  • 1Department of Nuclear Medicine, Avicenne University Hospital, Bobigny, France.

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|May 5, 2000
PubMed
Summary

Dipyridamole infusion temporarily boosts left ventricular ejection fraction (LVEF) and heart rate in healthy individuals. However, gated SPECT imaging 60 minutes post-infusion estimates resting LVEF due to recovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A very abnormal PET-CT].

La Revue de medecine interne·2016
Same author

Interaction-induced quantum phase revivals and evidence for the transition to the quantum chaotic regime in 1D atomic Bloch oscillations.

Physical review letters·2014
Same author

[Dyspnea and inflammatory syndrome].

La Revue de medecine interne·2014
Same author

Quantum quench in an atomic one-dimensional Ising chain.

Physical review letters·2013
Same author

[Increased uptake on PET/CT].

La Revue de medecine interne·2012
Same author

Superparamagnetic bifunctional bisphosphonates nanoparticles: a potential MRI contrast agent for osteoporosis therapy and diagnostic.

Journal of osteoporosis·2010

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Left ventricular function changes during dipyridamole infusion in healthy individuals remain uncharacterized by gated myocardial perfusion SPECT.
  • Previous studies have not utilized gated SPECT to assess dipyridamole's acute effects on cardiac function.

Purpose of the Study:

  • To investigate the acute effects of dipyridamole infusion on left ventricular function in healthy individuals using gated SPECT.
  • To determine the duration of these functional changes and their impact on imaging protocols.

Main Methods:

  • Eighteen healthy subjects underwent technetium-99m sestamibi gated SPECT imaging.
  • Images were acquired at rest, during dipyridamole infusion (0.76 mg/kg), and 1 hour post-infusion.
  • Left ventricular ejection fraction (LVEF), end-diastolic volume, and end-systolic volume were automatically calculated; heart rate and blood pressure were monitored.

Related Experiment Videos

Main Results:

  • Dipyridamole infusion significantly increased mean LVEF from 63.2% to 73.8% (P=.0001) and decreased end-systolic volume (P=.002).
  • Heart rate increased significantly (P<.001), while diastolic blood pressure slightly decreased (P<.001).
  • All measured parameters returned to baseline levels 1 hour after dipyridamole infusion.

Conclusions:

  • Dipyridamole infusion transiently enhances left ventricular ejection fraction and heart rate in healthy individuals.
  • The observed functional changes normalize within 1 hour post-infusion.
  • Standard dipyridamole gated SPECT protocols, initiating imaging 60 minutes after infusion, effectively assess resting left ventricular function.